NEONUCLEUS
LIVE

Serial Number

97271779

Owner

NEOGENOMICS LABORATORIES, INC.

Attorney

Anessa O. Kramer

Filing Date

Feb 17, 2022

Add to watchlist:

No watchlists yet
View on USPTO

NEONUCLEUS Trademark

Serial Number: 97271779

NEONUCLEUS is a trademark filed by NEOGENOMICS LABORATORIES, INC. on February 17, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 41 (Education & Entertainment), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 16 (Paper Goods). The application is currently pending registration.

Owner Contact Info

NEOGENOMICS LABORATORIES, INC. (83 trademarks)

12701 COMMONWEALTH DRIVE, SUITE 9
FORT MYERS, FL 33913

Entity Type: 03

Trademark Details

Filing Date

February 17, 2022

Registration Date

Not Registered

Goods & Services

Education services, namely, providing training and on-demand on-line training in the form of courses, seminars and workshops in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; Education services, namely, providing non-downloadable webinars in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions

Downloadable webinars in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; downloadable electronic publications in the nature of newsletters and abstracts in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions; downloadable or recorded computer software to acquire, capture, extract, except, analyze, organize, and manage medical testing, biological information, medical tests, medical test data, and medical test results for the processing of test data and for analysis of medical test results; downloadable or recorded computer software for the analysis of research, and review of information pertaining to medical, scientific, genetic, testing and analysis, and information and pertaining to testing and analysis

Printed publications, namely, articles, journals, newsletters and abstracts in the fields of pathology, medical testing, medical tests, diagnostic testing, oncology testing, human disease and human medical conditions

Medical information; medical diagnostic testing services in the field of human disease and human medical conditions; medical diagnostic testing, monitoring and reporting services; genetic testing for medical purposes; medical testing for diagnostic or treatment purposes; providing medical information to others in the field of human disease, human medical conditions, medical diagnostic testing, and medical testing for diagnostic or treatment purposes; providing an Internet website portal featuring medical information in the field of human disease, human medical conditions, medical diagnostic testing, medical testing for diagnostic or treatment purposes, and the delivery of scientific and medical test results; providing cloud-based medical information to others in the field of human disease, human medical conditions, medical diagnostic testing, and medical testing for diagnostic or treatment purposes

Medical laboratories; medical laboratory services; medical and scientific research information in the field of human disease and human medical conditions; medical laboratories, medical laboratory services; scientific testing and research services in the field of human disease and human medical conditions; providing medical research services in the field of human disease and human medical conditions; providing clinical scientific testing services and medical research and testing in the field of human disease and human medical conditions; clinical laboratory services, oncology reference laboratory services; providing information, and reports to others in the field of medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions; providing information on medical tests, medical testing, medical research, pathology, diagnostic testing, oncology testing and human disease and medical conditions via an interactive website; providing information to others in the field of scientific testing and research and clinical scientific testing; providing an internet website portal featuring information in the field of scientific testing and research, medical research, and clinical scientific testing; providing cloud-based information to others in the field of scientific testing and research, medical research, and clinical scientific testing; providing online non-downloadable Internet-based software for medical testing and analysis of medical test results; providing online non-downloadable Internet-based software for analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; Software as a service (SAAS) services featuring software for medical testing and analysis of medical test results; Software as a service (SAAS) services featuring software for analyzing, researching, and reviewing of medical, scientific, and genetic information, testing and analysis; genetic mapping for scientific purposes, namely, gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; medical and scientific research information in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells; scientific research in the field of gene sequencing, molecular sequencing, cancer study and analysis, cytometry, cytogenetics, cell analysis, cell preservation, clinical study and testing of cells, and cancer

Filing History

REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 19, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 18, 2025 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 5, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Mar 6, 2024 RCSC
REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Sep 5, 2023 RCSC
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 7, 2023 GNS3
LETTER OF SUSPENSION E-MAILED
Mar 7, 2023 GNSL
SUSPENSION LETTER WRITTEN
Mar 7, 2023 CNSL
TEAS/EMAIL CORRESPONDENCE ENTERED
Feb 22, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Feb 21, 2023 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Feb 21, 2023 TROA
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 1, 2023 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 1, 2023 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Feb 1, 2023 COAR
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 16, 2022 GNRN
NON-FINAL ACTION E-MAILED
Nov 16, 2022 GNRT
NON-FINAL ACTION WRITTEN
Nov 16, 2022 CNRT
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Nov 10, 2022 CHAN
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 10, 2022 TCCA
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Nov 10, 2022 COAR
TEAS/EMAIL CORRESPONDENCE ENTERED
Sep 20, 2022 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Sep 19, 2022 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sep 19, 2022 TROA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 13, 2022 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Jun 13, 2022 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 13, 2022 REAP
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 28, 2022 GNRN
NON-FINAL ACTION E-MAILED
Mar 28, 2022 GNRT
NON-FINAL ACTION WRITTEN
Mar 28, 2022 CNRT
ASSIGNED TO EXAMINER
Mar 20, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Feb 23, 2022 NWOS
NEW APPLICATION ENTERED
Feb 21, 2022 NWAP